Implications of LINE1 methylation for bladder cancer risk in women

Clinical Cancer Research

Volumn 16, Issue 5, 2010, Pages 1682-1689

  Wilhelm, Charlotte S ^a   Kelsey, Karl T ^a,b   Butler, Rondi ^a,b   Plaza, Silvia ^a,b   Gagne, Luc ^b   Zens, M Scot ^c   Andrew, Angeline S ^c   Morris, Steven ^d   Nelson, Heather H ^e   Schned, Alan R ^c   Karagas, Margaret R ^c   Marsit, Carmen J ^b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DNA EXTRACTION; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; FEMALE; GENE MUTATION; GENETIC LINE; HISTOPATHOLOGY; HUMAN; INFORMED CONSENT; INTERVIEW; LONG INTERSPERSED REPEAT; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENCE; SMOKING;

ADULT; AGED; DNA METHYLATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 77649083131     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-2983     Document Type: Article

References (42)

1. American Cancer Society, Cancer facts and Figures 2009, Atlanta (GA): American Cancer Society. 2009; 500809; 5.
2. Brown LM, Zahm SH, Hoover RN, Fraumeni JF, Jr. High bladder cancer mortality in rural New England (United States): an etiologic study. Cancer Causes Control 1995;6:361-8.
3. Parkin MP. The global burden of urinary bladder cancer. Scand J Urol Nephrol 2008;42:12-20.
4. Dinney CP, McConkey DJ, Millikan RE, et al. Focus on bladder cancer. Cancer Cell 2004;6:111-6.
5. Karagas MR, Tosteson TD, Morris JS, et al. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 2004;15:465-72.
6. Boffetta P. Human cancer from environmental pollutants: the epidemiological evidence. Mutat Res 2006;608:157-62.
7. Abernathy CO, Liu YP, Longfellow D, et al. Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect 1999;107:593-7.
8. Bates MN, Smith AH, Cantor KP. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 1995;141:523-30.
9. Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect 1999;107:705-10.
10. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction. Nat Rev Cancer 2006;6:107-16.
11. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28.
12. Marsit CJ, Karagas MR, Danaee H, et al. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 2006;27:112-6.
13. Marsit CJ, Houseman EA, Schned AR, Karagas MR, Kelsey KT. Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer. Carcinogenesis 2007;28:1745-51.
14. Wolff EM, Liang G, Jones PA. Mechanisms of disease: genetic and epigenetic alterations that drive bladder cancer. Nat Clin Pract Urol 2005;2:502-10.
15. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983;301:89-92.
16. Jiang L, Gonda TA, Gamble MV, et al. Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Res 2008;68:9900-8.
17. Chalitchagorn K, Shuangshoti S, Hourpai N, et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 2004;23:8841-6.
18. Hsiung DT, Marsit CJ, Houseman EA, et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2007;16:108-14.
19. Issa J. Aging, DNA methylation and cancer. Crit Rev Oncol Hematol 1999;32:31-43.
20. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007;1775:138-62.
21. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002;16:6-21.
22. Smith SS, Crocitto L. DNA methylation in eukaryotic chromosome stability revisited: DNA methyltransferase in the management of DNA conformation space. Mol Carcinog 1999;26:1-9.
23. Figueiredo JC, Grau MV, Wallace K, et al. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 2009;18:1041-9.32.
24. Rusiecki JA, Baccarelli A, Bollati V, Tarantini L, Moore LE, Bonefeld-Jorgensen EC. Global DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic Inuit. Environ Health Perspect 2008;116:1547-52.
25. Tarantini L, Bonzini M, Apostoli P, et al. Effects of particulate matter on genomic DNA methylation content and iNOS promoter methylation. Environ Health Perspect 2009;117:217-22.
26. Bollati V, Baccarelli A, Hou L, et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 2007;67:876-80.
27. Moore LE, Pfeiffer RM, Poscablo C, et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol 2008;9:359-66.
28. Graziano F, Kawakami K, Ruzzo A, et al. Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int J Cancer 2006;118:628-32.
29. Karagas MR, Tosteson TD, Blum J, Morris JS, Baron JA, Klaue B. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect 1998;106:1047-50.
30. Karagas MR, Stukel TA, Morris JS, et al. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol 2001;153:559-65.
31. England RPM. Pyro Q-CpG2: quantitative analysis of methylation in multiple CpG sites by PyrosequencingR. Nat Methods 2005;2:1-2.
32. Karagas MR, Park S, Nelson HH, et al. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study. Int J Hyg Environ Health 2005;208:321-7.
33. Wallace K, Kelsey KT, Schned A, Morris JS, Andrew AS, Karagas MR. Selenium and risk of bladder cancer: a population-based case-control study. Cancer Prev Res (Phila Pa) 2009;2:70-3.
34. El-Maarri O, Becker T, Junen J, et al. Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males. Hum Genet 2007;122:505-14.
35. Zhong CX, Mass MJ. Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR. Toxicol Lett 2001;122:223-34.
36. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci U S A 1997;94:10907-12.
37. Chen H, Li S, Liu J, Diwan BA, Barrett JC, Waalkes MP. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis 2004;25:1779-86.
38. Pilsner JR, Liu X, Ahsan H, et al. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ Health Perspect 2009;117:254-60.
39. Pilsner JR, Liu X, Ahsan H, et al. Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults. Am J Clin Nutr 2007;86:1179-86.
40. Kaneda A, Tsukamoto T, Takamura-Enya T, et al. Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci 2004;95:58-64.
41. Weisenberger DJ, Campan M, Long TI, et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005;33:6823-36.
42. Sassaman DM, Dombroski BA, Moran JV, et al. Many human L1 elements are capable of retrotransposition. Nat Genet 1997;16:37-43.